Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Shanghai Toujing Life Technology Co., Ltd. (referred to as "Toujing Life") was established in 2003, headquartered in Zhangjiang High tech Park, Shanghai. It specializes in the research and development, production, promotion, and sales of high-end in vitro diagnostic products, and is committed to promoting the application of new testing technologies in the field of clinical testing. Toujing Life was successfully listed on April 21, 2017, with stock code 300642. At present, we have obtained nearly 300 medical device registration certificates, forming a series of products with flow cytometry fluorescence technology, chemiluminescence technology, multiple fluorescence PCR technology, and liquid chromatography tandem mass spectrometry technology as the main technology platforms, and with the main application directions of tumor monitoring, autoimmune, cardiovascular disease, pathogen infection, and reproductive health. Together with Hitachi Diagnostics, we have launched the Hitachi Translucent Compatibility Assembly Line, A new mode of domestic compatibility assembly line has been opened. Thoroughview Life adheres to the concept of "docking with global technology resources, based on local innovation and creation", and strives to become a company with international influence in the field of life science and technology, making contributions to human health. |
Headquarter | Shanghai |
Establish Date | 11/6/2003 |
Listed Code | 300642.SZ |
Listed Date | 4/21/2017 |
Chairman | Yao Jian'er. |
CEO | Yao Jian'er. |
Website | www.tellgen.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial